Now accepting Telehealth appointments. Schedule a virtual visit.

Roozbeh Sharif, MD

Pulmonologist located in Port Arthur, TX

About Dr. Sharif

Roozbeh Sharif, MD, is a critical care and pulmonary medicine specialist at Texas Pulmonary Institute, located in Port Arthur, Texas. He is board certified in internal medicine, pulmonary medicine, and critical care medicine.

Dr. Sharif earned his medical degree at Shahid Beheshti Medical University, located in Tehran, Iran. He then relocated to the United States where he completed a postdoctoral research fellowship at the University of Texas Health Science Center, located in Houston. He completed a Master of Education at the University of Houston, College of Education, and a Master of Medical Science at the University of Texas Medical Branch located in Galveston. Dr. Sharif also completed his residency and internship in internal medicine at the University of Texas Medical Branch located in Galveston. He rounded out his medical training with a fellowship in pulmonary and critical care medicine at the University of Alabama at Birmingham and Duke University, in Durham, North Carolina.

In addition to his position at Texas Pulmonary Institute, he is also the Medical Director of the respiratory therapy department at the Medical Center of Southeast Texas. Previously, Dr. Sharif has held ICU Medical Director positions in Houston and Corpus Christi, Texas. In addition to his clinical experience, Dr. Sharif has held academic appointments at the Institute of Academic Medicine and Weill-Cornell School of Medicine until May 2019.

He has also contributed his expertise to several research studies, publications, and presentations. A few highlighted below:

1. Sharif R. Overview of idiopathic pulmonary fibrosis (IPF) and evidence-based guidelines. Am J Manag Care. 2017 Jul;23(11 Suppl):S176-S182.
2. Semler MW, Janz DR, Russell DW, Check-UP Investigatorsāˆ—. Pragmatic Critical Care Research Group. A Multicenter, Randomized Trial of Ramped Position vs Sniffing Position During Endotracheal Intubation of Critically Ill Adults. Chest. 2017 Oct;152(4):712-722.
3. Sharif R, Parekh TM, Pierson KS, et al. Predictors of Early Readmission among Patients Aged 40 to 64 Years Hospitalized for Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2014. Jun;11(5):685-94.
4. Sharif R, Cuevas CR, Wang Y, et al. Guideline adherence in management of stable chronic obstructive pulmonary disease. Respir Med. 2013, 107(7): 1046-52.
5. Merz EL, Malcarne VL, Sharif R, et al. Measuring illness behavior in patients with systemic sclerosis. Arthritis Care Res (Hoboken). 2013, 65(4): 585-93.
6. Sharif R, Mayes MD, Tan FK, et al. IRF5 polymorphism predicts prognosis in patients with systemic sclerosis. Ann Rheum Dis. 2012; 71(7):1197-202.
7. Assassi S, Leyva AL, Sharif R, et al. Predictors of fatigue severity in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort. PLoS One. 2011; 6(10).
8. Sharif R, Fritzler MJ, Mayes MD, et al. Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis. J Rheumatol. 2011 Aug; 38(8): 1622-30.
9. Sharif R, Mayes MD, Nicassio PM, et al. Determinants of work disability in patients with systemic sclerosis: a longitudinal study of the GENISOS cohort. Semin Arthritis Rheum. 2011; 41(1):38-47.
10. Assassi S, Sharif R, Lasky RE, et al. Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort. Arthritis Res Ther. 2010; 12(5): R166.

Read more

Roozbeh Sharif, MD, is a critical care and pulmonary medicine specialist at Texas Pulmonary Institute, located in Port Arthur, Texas. He is board certified in internal medicine, pulmonary medicine, and critical care medicine.

Dr. Sharif earned his medical degree at Shahid Beheshti Medical University, located in Tehran, Iran. He then relocated to the United States where he completed a postdoctoral research fellowship at the University of Texas Health Science Center, located in Houston. He completed a Master of Education at the University of Houston, College of Education, and a Master of Medical Science at the University of Texas Medical Branch located in Galveston. Dr. Sharif also completed his residency and internship in internal medicine at the University of Texas Medical Branch located in Galveston. He rounded out his medical training with a fellowship in pulmonary and critical care medicine at the University of Alabama at Birmingham and Duke University, in Durham, North Carolina.

In addition to his position at Texas Pulmonary Institute, he is also the Medical Director of the respiratory therapy department at the Medical Center of Southeast Texas. Previously, Dr. Sharif has held ICU Medical Director positions in Houston and Corpus Christi, Texas. In addition to his clinical experience, Dr. Sharif has held academic appointments at the Institute of Academic Medicine and Weill-Cornell School of Medicine until May 2019.

He has also contributed his expertise to several research studies, publications, and presentations. A few highlighted below:

1. Sharif R. Overview of idiopathic pulmonary fibrosis (IPF) and evidence-based guidelines. Am J Manag Care. 2017 Jul;23(11 Suppl):S176-S182.
2. Semler MW, Janz DR, Russell DW, Check-UP Investigatorsāˆ—. Pragmatic Critical Care Research Group. A Multicenter, Randomized Trial of Ramped Position vs Sniffing Position During Endotracheal Intubation of Critically Ill Adults. Chest. 2017 Oct;152(4):712-722.
3. Sharif R, Parekh TM, Pierson KS, et al. Predictors of Early Readmission among Patients Aged 40 to 64 Years Hospitalized for Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2014. Jun;11(5):685-94.
4. Sharif R, Cuevas CR, Wang Y, et al. Guideline adherence in management of stable chronic obstructive pulmonary disease. Respir Med. 2013, 107(7): 1046-52.
5. Merz EL, Malcarne VL, Sharif R, et al. Measuring illness behavior in patients with systemic sclerosis. Arthritis Care Res (Hoboken). 2013, 65(4): 585-93.
6. Sharif R, Mayes MD, Tan FK, et al. IRF5 polymorphism predicts prognosis in patients with systemic sclerosis. Ann Rheum Dis. 2012; 71(7):1197-202.
7. Assassi S, Leyva AL, Sharif R, et al. Predictors of fatigue severity in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort. PLoS One. 2011; 6(10).
8. Sharif R, Fritzler MJ, Mayes MD, et al. Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis. J Rheumatol. 2011 Aug; 38(8): 1622-30.
9. Sharif R, Mayes MD, Nicassio PM, et al. Determinants of work disability in patients with systemic sclerosis: a longitudinal study of the GENISOS cohort. Semin Arthritis Rheum. 2011; 41(1):38-47.
10. Assassi S, Sharif R, Lasky RE, et al. Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort. Arthritis Res Ther. 2010; 12(5): R166.


Read less

Insurance

We do accept all insurances. For any additional questions please contact our office.

AARP
Aetna
AgeWell
AHCCCS Plans
AIG